Position
Creative Planning in Acadia Pharmaceuticals Inc
Back to the book · All holders of ACAD
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$195.9K$26.71 → $22.26
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 44K | $1.18M | — | — | — | 0.0% |
| Q1 2026 | 47.5K | $1.06M | $22.26 | −$195.9K | $76.9K | 0.0% |